Practice Point | Published:

Does androgen deprivation therapy in men with prostate cancer increase cardiovascular morbidity?

Nature Clinical Practice Urology volume 5, pages 8081 (2008) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    et al. (2006) Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24: 4448–4456

  2. 2.

    et al. (2007) Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst 99: 1516–1524

  3. 3.

    et al. (2007) Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 25: 2420–2425

  4. 4.

    et al. (2002) Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 87: 599–603

  5. 5.

    et al. (2006) The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters. J Urol 176: 520–525

  6. 6.

    et al. (2006) Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab 91: 1305–1308

Download references


The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information


  1. SM Corsello is a medical student at Harvard Medical School and is PW Kantoff is Chief Clinical Research Officer, Chief of the Division of Solid Tumor Oncology, and Director of the Lank Center for Genitourinary Oncology, Dana–Farber Cancer Institute, and Professor of Medicine at Harvard Medical School, Boston, MA, USA.

    • Steven M Corsello
    •  & Philip W Kantoff


  1. Search for Steven M Corsello in:

  2. Search for Philip W Kantoff in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Philip W Kantoff.

About this article

Publication history





Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing